Therefore, we hypothesized that epalrestat could inhibit the apoptosis and autophagy of BMVECs through the ATK/mTOR signaling pathway to maintain endothelial cell barrier function, and thus protect against BBB damage and further injury in cerebral ischemia. Here, MTOR is linked to brain ischemia.